[
  {
    "ts": null,
    "headline": "Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug",
    "summary": "Bristol Myers Squibb",
    "url": "https://finnhub.io/api/news?id=d6900ef6223813a6c4a2ae8bf2995131189835f2af94179698df4014836a4f6a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731628136,
      "headline": "Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug",
      "id": 131365659,
      "image": "https://media.zenfs.com/en/reuters-finance.com/bdb9a0de7e5804419b8ce1a102bf7c01",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers Squibb",
      "url": "https://finnhub.io/api/news?id=d6900ef6223813a6c4a2ae8bf2995131189835f2af94179698df4014836a4f6a"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
    "summary": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=aa54949db4c4259d6631e8200cbf6412c54857aa235deb1ba39baf6cb2887fd5",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731602460,
      "headline": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
      "id": 131417100,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=aa54949db4c4259d6631e8200cbf6412c54857aa235deb1ba39baf6cb2887fd5"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company's (NYSE:BMY) high institutional ownership speaks for itself as stock continues to impress, up 5.7% over last week",
    "summary": "Key Insights Significantly high institutional ownership implies Bristol-Myers Squibb's stock price is sensitive to...",
    "url": "https://finnhub.io/api/news?id=6150795787c40d2dade921651232acf1c143980577306f22f18507634e1b870e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731592879,
      "headline": "Bristol-Myers Squibb Company's (NYSE:BMY) high institutional ownership speaks for itself as stock continues to impress, up 5.7% over last week",
      "id": 131350121,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/61ae5b4abdbb9c040fe4f1989e525046",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Key Insights Significantly high institutional ownership implies Bristol-Myers Squibb's stock price is sensitive to...",
      "url": "https://finnhub.io/api/news?id=6150795787c40d2dade921651232acf1c143980577306f22f18507634e1b870e"
    }
  },
  {
    "ts": null,
    "headline": "2 Beaten-Down Dividend Stocks to Buy and Hold",
    "summary": "They're down, but they aren't out, at least not in the eyes of patient investors.",
    "url": "https://finnhub.io/api/news?id=5aae0cf661a8b73fdf05f1e5ffd806db4dcb80ff52437c61e57f0a29336b748a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731589200,
      "headline": "2 Beaten-Down Dividend Stocks to Buy and Hold",
      "id": 131348698,
      "image": "https://g.foolcdn.com/editorial/images/796833/pharmacist-talking-to-patient.jpg",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "They're down, but they aren't out, at least not in the eyes of patient investors.",
      "url": "https://finnhub.io/api/news?id=5aae0cf661a8b73fdf05f1e5ffd806db4dcb80ff52437c61e57f0a29336b748a"
    }
  }
]